DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression

[1]  P. Scheet,et al.  Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome , 2018, JAMA Oncology.

[2]  M. Kloor,et al.  Three molecular pathways model colorectal carcinogenesis in Lynch syndrome , 2018, International journal of cancer.

[3]  R. Wolff,et al.  Mutation analysis of adenomas and carcinomas of the colon: Early and late drivers , 2018, Genes, chromosomes & cancer.

[4]  L. Holm,et al.  Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer , 2018, Carcinogenesis.

[5]  P. Peltomäki,et al.  Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations , 2017, Oncotarget.

[6]  Steve Hoffmann,et al.  Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome , 2017, The Journal of pathology.

[7]  Shih-Cheng Chang,et al.  Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer , 2017, Oncotarget.

[8]  P. Møller,et al.  Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database , 2017, Gut.

[9]  Teruhiko Yoshida,et al.  Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis , 2017, Modern Pathology.

[10]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[11]  J. Melson,et al.  LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer , 2017, Clinical Epigenetics.

[12]  Mingming Jia,et al.  COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..

[13]  Teruhiko Yoshida,et al.  Mismatch repair deficiency in Lynch syndrome‐associated colorectal adenomas is more prevalent in older patients , 2016, Histopathology.

[14]  M. Kloor,et al.  CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome , 2016, Familial Cancer.

[15]  P. Møller,et al.  Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database , 2015, Gut.

[16]  A. Ristimäki,et al.  DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas , 2015, Clinical Epigenetics.

[17]  T. Zander,et al.  Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer , 2015, Gut.

[18]  C. Boland,et al.  Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case , 2015, Familial Cancer.

[19]  K. Søreide,et al.  Comparison of CpG Island Methylator Phenotype (CIMP) Frequency in Colon Cancer Using Different Probe- and Gene-Specific Scoring Alternatives on Recommended Multi-Gene Panels , 2014, PloS one.

[20]  Rodney J Scott,et al.  Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.

[21]  N. Reyhani,et al.  Cancer-Predicting Gene Expression Changes in Colonic Mucosa of Western Diet Fed Mlh1 +/- Mice , 2013, PloS one.

[22]  A. Ristimäki,et al.  BRAF mutation in sporadic colorectal cancer and Lynch syndrome , 2013, Virchows Archiv.

[23]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[24]  Jeffrey J Meyer,et al.  Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012. (5) , 2013 .

[25]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[26]  C. Boland,et al.  A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer , 2012, PloS one.

[27]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[28]  Axel Benner,et al.  Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study. , 2012, The Lancet. Oncology.

[29]  A. Spurdle,et al.  Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification , 2012, Journal of Medical Genetics.

[30]  Yasushi Totoki,et al.  Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency. , 2012, Genome research.

[31]  C. Boland,et al.  Microsatellite Instability and DNA Mismatch Repair Protein Deficiency in Lynch Syndrome Colorectal Polyps , 2012, Cancer Prevention Research.

[32]  P. Peltomäki,et al.  LINE-1 hypomethylation in familial and sporadic cancer , 2012, Journal of Molecular Medicine.

[33]  William M. Grady,et al.  Epigenetics and colorectal cancer , 2011, Nature Reviews Gastroenterology &Hepatology.

[34]  S. Tavaré,et al.  Sequential DNA methylation changes are associated with DNMT3B overexpression in colorectal neoplastic progression , 2010, Gut.

[35]  L. Qin,et al.  Improved Testing for Microsatellite Instability in Colorectal Cancer Using a Simplified 3-Marker Assay , 2010, Annals of Surgical Oncology.

[36]  C. Boland,et al.  Microsatellite instability in colorectal cancer. , 2010, Gastroenterology.

[37]  P. Deininger,et al.  LINE dancing in the human genome: transposable elements and disease , 2009, Genome Medicine.

[38]  M. Batzer,et al.  The impact of retrotransposons on human genome evolution , 2009, Nature Reviews Genetics.

[39]  F. Nagengast,et al.  In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response , 2009, Histopathology.

[40]  G. Fontanini,et al.  KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer , 2009, British Journal of Cancer.

[41]  Shuji Ogino,et al.  CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer , 2008, Gut.

[42]  R. Jaenisch,et al.  Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice , 2008, Oncogene.

[43]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[44]  Sarah Edkins,et al.  Recurrent KRAS codon 146 mutations in human colorectal cancer , 2006, Cancer biology & therapy.

[45]  M. Kloor,et al.  Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study , 2006, International Journal of Colorectal Disease.

[46]  J. Schouten,et al.  Methylation-Specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences , 2005, Nucleic acids research.

[47]  A. Lindblom,et al.  Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer , 2005, Modern Pathology.

[48]  J. Jiricny,et al.  Methylation‐induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1 , 2003, The EMBO journal.

[49]  G. Deng,et al.  Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer , 2002, British Journal of Cancer.

[50]  L. Aaltonen,et al.  Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). , 2001, Cancer research.

[51]  B. Leggett,et al.  DNA microsatellite instability and mismatch repair protein loss in adenomas presenting in hereditary non-polyposis colorectal cancer , 2000, Gut.

[52]  S. Devries,et al.  Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. , 1994, The American journal of pathology.

[53]  A. Chapelle,et al.  Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer , 1994, Nature Genetics.

[54]  G. Cooper,et al.  Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins , 1988, Molecular and cellular biology.

[55]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[56]  P. Eilers,et al.  The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. , 2004, Gastroenterology.

[57]  A. Rowan,et al.  Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours , 1998, Human mutation.